US$ 24.09
semaglutide and ra Weight Loss Stories like this are why
Description
The latter should not be used
Although there is no GLP-1RA approved for the treatment of AS, these findings could provide novel approaches for the treatment of AS

Drugs.com (2024)
However, long-term studies are needed to evaluate weight loss durability and the potential need for continuous therapy

Weintraub WS, Bhatt DL, Zhang Z, et al

6,7 Berberine, typically dosed around 500 mg three times daily, has demonstrated therapeutic potential for diabetes and lipid disorders, comparable to pharmaceuticals like metformin
